Summary: Freethink reports on the long-term follow-up results of a combined analysis of six double-blind Phase 2 clinical trials of MDMA-assisted psychotherapy for PTSD. The results showed that 12 months after treatment, 67% of participants no longer met the criteria for PTSD. This discovery shows that MDMA-assisted psychotherapy for PTSD, “could be even more useful for overcoming trauma than previously thought,” says Freethink.
Originally appearing here.
